SB 1260 - Currently, a physician or other health care provider shall draw and test a pregnant woman's blood at or soon after her first prenatal examination, with her consent, for syphilis, hepatitis B, or other similar diseases. Under this act, the testing of the pregnant woman's blood shall also occur at the twenty-eighth week of her pregnancy. Additionally, the test shall include hepatitis C and HIV. If a mother tests positive for syphilis, hepatitis B, hepatitis C, or HIV, the physician or other health care provider shall treat the mother in accordance with the most recent accepted medical practice.

Current law requires the Department of Health and Senior Services to work in consultation with the Missouri Genetic Disease Advisory Committee to make rules pertaining to these blood tests. This act repeals the requirement to work with the Committee and requires that the tests be approved or accepted by the U.S. Food and Drug Administration.

This act is substantially similar to a provision in HCS/HB 2413 (2024).

SARAH HASKINS

Statutes affected:
Introduced (4670S.01): 210.030

---

Senate Committee Minutes:
SENATE COMMITTEE MINUTES Bill No.: SB 1260
Sponsor: Gannon
Hearing Date: 3/6/2024


COMMITTEE: Health and Welfare

CHAIRMAN: Coleman

DATE REFERRED: 1/25/2024 DATE HEARING REQUESTED:



STAFF:
Sarah Haskins
Heidi Kolkmeyer
Karen Roach
Seth York


WITNESSES GIVING INFORMATION:



WITNESSES FOR:
Katie Gamble - Missouri enter for Public Health Excellence & American College of Obstetricians and Gynecologists
Garrett Webb - Missouri Chapter, American Academy of Pediatrics
Chase Campbell - St. Louis Children's Hospital
Deanna Hemphill - Missouri State Medical Association


WITNESSES AGAINST: